Showing results (1-10 of 293) with videos related to
Sort By:
Pageof 30
Science Translational Medicine|May 4, 2018
ER stress in prostate cancer: A therapeutically exploitable vulnerability?Christopher Logothetis, Ana Aparicio, Timothy C ThompsonPathology|December 23, 2019
Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progressionVasiliki Tzelepi, Souzana Logotheti, Eleni Efstathiou, et al.Oncology (Williston Park, N.Y.)|July 11, 2002
Docetaxel in the management of advanced or metastatic urothelial tract cancerChristopher Logothetis, Randall MillikanInternational Journal of Cancer|October 23, 2008
Targeting Src signaling in metastatic bone diseaseJohn Araujo, Christopher LogothetisCancer Treatment Reviews|March 16, 2010
Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumorsJohn Araujo, Christopher LogothetisClinical Lung Cancer|April 28, 2006
The potential of histone deacetylase inhibitors in lung cancerAna AparicioCancer Cell|June 15, 2010
Grappling with the androgen receptor: a new approach for treating advanced prostate cancerTimothy C ThompsonCancer Cell|November 13, 2007
Suppression of tumor suppressors in prostate cancer: the emergence of a novel oncogenic pathwayTimothy C ThompsonCancer Cell|June 14, 2011
Turning reciprocal feedback regulation into combination therapyTimothy C ThompsonYonsei Medical Journal|May 26, 2010
Glioma pathogenesis-related protein 1: tumor-suppressor activities and therapeutic potentialTimothy C ThompsonPageof 30